Group 1 - The company held a temporary board meeting where all five participating directors voted in favor of several key proposals [1][2][3] - The company plans to appoint Jiang Xin and Zhou Yanqi as non-independent directors, pending approval at the first temporary shareholders' meeting in 2025 [1][2] - The company intends to change its name to "Guhan Health Industry Group Co., Ltd." to better reflect its main business and enhance brand recognition [2][3] Group 2 - The company expects to engage in daily operational related transactions with its shareholder's affiliate, Hunan Hengchang Pharmaceutical Group Co., Ltd., with a total transaction amount not exceeding 50 million yuan in 2025 [2][3] - A temporary shareholders' meeting is scheduled for September 22, 2025, to discuss the aforementioned proposals [3][4] - All proposals from the board meeting require approval at the upcoming shareholders' meeting [4]

Meeting Overview - The company will hold its first extraordinary general meeting of 2025 on September 8, 2025 [1][2] - The meeting will be convened by the board of directors and is compliant with relevant laws and regulations [1][10] Meeting Details - The meeting will take place at 2:45 PM on September 8, 2025, with network voting available throughout the day [2][3] - Shareholders can vote either in person or via online platforms provided by the Shenzhen Stock Exchange [4][16] Attendance and Registration - Shareholders registered by the close of business on September 3, 2025, are eligible to attend [5][6] - Registration for attendance can be done in person or through authorized representatives [12][13] Agenda Items - The meeting will include proposals for amending the company's articles of association and electing a non-independent director [15][10] - A special resolution requires approval from at least two-thirds of the voting rights present [10][11] Voting Procedures - Voting will be conducted through both physical attendance and online systems, with specific time slots for online voting [3][18] - All proposals are non-cumulative voting items, and the first valid vote will be considered in case of duplicate votes [17][19] Additional Information - The company will not cover travel expenses for attending shareholders [20] - Contact information for inquiries is provided, including phone and fax numbers [21]

Core Viewpoint - The company is convening its first extraordinary general meeting of shareholders in 2025 to ensure the protection of shareholders' legal rights and maintain the order and efficiency of the meeting [1][2]. Meeting Details - The meeting is scheduled for July 31, 2025, at 13:30, located at the company's conference room in Shanghai [5]. - Voting will be conducted through a combination of on-site and online methods, with specific time slots for internet voting [5]. Meeting Agenda - The agenda includes sign-in, distribution of materials, and registration for speaking [6]. - The chairman will announce the number of attending shareholders and their voting rights before proceeding with the meeting [6]. Proposals for Consideration - Proposal 1: Election of a new non-independent director to replace the resigned director, with the candidate being Mao Xinyong [6][7]. - Proposal 2: Adjustment of the 2025 director remuneration plan, specifically for non-independent directors not holding executive positions, proposing a consultant allowance of RMB 100,000 per year [8]. - Proposal 3: Formulation and revision of certain internal governance systems, in compliance with relevant laws and regulations [9][10]. Additional Proposals - Several additional proposals regarding the management of various internal systems, including external guarantees, external investments, and fundraising management, are also set for discussion [10][11].